Exelixis | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Amgen USD 694M 29M 2025-06
AstraZeneca 303M 126M 2025-06
Bayer 495M 89M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Cytokinetics USD 24.26M 1.32M 2025-06
Eisai 916M 174M 2025-06
Eli Lilly USD 249M 5.3M 2025-06
Exelixis 23.4M 3.9M 2023-09
Genmab DKK 9M 4M 2025-06
Glaxosmithkline 184M 5.95M 2025-06
Incyte USD 594K 66K 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
MacroGenics USD 802K 826K 2025-06
Merck USD 305M 8M 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
Pfizer USD 654M 0 2025-06
Sanofi 62M 4.11M 2025-06
Takeda 107.16B 56.83B 2025-06
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
Xencor 8.24M 422K 2025-06


Exelixis Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.